for

CMSI PARTNERS ANNOUNCE THE FINAL PUBLIC CONSULTATION FOR THE CONSOLIDATED MINING STANDARD TO START ON 8 OCTOBER 2025

Stakeholders and rights-holders are encouraged to submit feedback, and help shape the future of mining LONDON, Oct. 8, 2025 /PRNewswire/…

2 months ago

From AI to Creativity: The ToyTrends for Spielwarenmesse 2026

"AI Loves (to) Play": Intelligent toys for interactive play experiences "Creative Mindfulness": Creative activities, creating special moments NUREMBERG, Germany, Oct.…

2 months ago

Signs of Change: Equipping Teachers with Tools for Inclusive Classrooms

Education Cannot Wait-funded initiative, implemented by Light for the World and Save the Children, trains teachers in sign language and…

2 months ago

Open Compute Project Foundation and iMasons Develop Taxonomy for Carbon Disclosure

New Specification for Embodied Carbon Harmonizes Reporting Across the DC Industry AUSTIN, Texas, Oct. 7, 2025 /PRNewswire/ -- The Open…

2 months ago

2025 International MICE Summit (IMS) to convene global leaders as Vision 2030 powers Saudi Arabia’s rise as a global hub for business events

Over 2,000 global industry and government leaders will attend the second edition of the International MICE Summit (IMS25) in Riyadh,…

2 months ago

Aisera Recognized as a Leader in the IDC MarketScape for Worldwide General-Purpose Conversational AI Platforms

October 07, 2025 11:00 ET  | Source: Aisera SANTA CLARA, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Aisera, a leading…

2 months ago

AscellaHealth Leaders Take the Stage at SIIA National Conference: Present Strategies for Managing High-Cost Claims and Building Pharma Partnerships

BERWYN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical…

2 months ago

Milliken & Company Launches Millad ClearX 9000: The Clear Choice for Polypropylene

Delivers exceptional clarity with lower additive levels, streamlining production and expanding formulation options for converters and resin producers SPARTANBURG, S.C.,…

2 months ago

BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease

Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants Secondary…

2 months ago

NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month

The National Comprehensive Cancer Network expands interactive library of evidence-based, expert consensus-driven cancer care guidance to now cover treatment for…

2 months ago